Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
ATOS similar filings
- 28 Jun 23 Atossa Therapeutics Announces $10M Stock Repurchase Program
- 23 Jun 23 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 1 Jun 23 Departure of Directors or Certain Officers
- 22 May 23 Changes in Registrant's Certifying Accountant
- 15 May 23 Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
- 4 May 23 Submission of Matters to a Vote of Security Holders
- 26 Apr 23 Amendments to Articles of Incorporation or Bylaws
Filing view
External links
Exhibit 16.1
May 22, 2023
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on May 17, 2023, to be filed by our former client, Atossa Therapeutics, Inc. We agree with the statements made in response to that Item insofar as they relate to our Firm.
Very truly yours,
/s/ BDO USA LLP